{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T04:10:31Z","timestamp":1759032631102,"version":"3.37.3"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2016,6,11]],"date-time":"2016-06-11T00:00:00Z","timestamp":1465603200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","award":["Health Technology Appraisal Programme 12\/66\/01"],"award-info":[{"award-number":["Health Technology Appraisal Programme 12\/66\/01"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["PharmacoEconomics"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1007\/s40273-016-0417-9","type":"journal-article","created":{"date-parts":[[2016,6,11]],"date-time":"2016-06-11T01:25:18Z","timestamp":1465608318000},"page":"901-912","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["The Clinical and Cost Effectiveness of Vortioxetine for the Treatment of a Major Depressive Episode in Patients With Failed Prior Antidepressant Therapy: A Critique of the Evidence"],"prefix":"10.1007","volume":"34","author":[{"given":"James","family":"Lomas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexis","family":"Llewellyn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Soares","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Simmonds","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kath","family":"Wright","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alison","family":"Eastwood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen","family":"Palmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,6,11]]},"reference":[{"key":"417_CR1","unstructured":"NICE. Guide to the single technology appraisal process. 2009. Available at: https:\/\/www.nice.org.uk\/Media\/Default\/About\/what-we-do\/NICE-guidance\/NICE-technology-appraisals\/Guide-to-the-single-technology-appraisal-process.pdf . Accessed 2 June 2016."},{"key":"417_CR2","unstructured":"Simmonds M, Lomas J, Llewellyn A, Soares M, Wright K, Eastwood A, et al. Vortioxetine for treating major depressive disorder: a single technology appraisal. CRD\/CHE Technology Assessment Group; 2015."},{"key":"417_CR3","unstructured":"NICE. Vortioxetine for treating major depressive episodes. 2015. Available at: https:\/\/www.nice.org.uk\/guidance\/ta367 ."},{"key":"417_CR4","unstructured":"NICE. Depression in adults: recognition and management. 2009. Available at: https:\/\/www.nice.org.uk\/Guidance\/CG90 . Accessed 2 June 2016."},{"issue":"6","key":"417_CR5","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/S0895-4356(97)00049-8","volume":"50","author":"HC Bucher","year":"1997","unstructured":"Bucher HC, Guyatt GH, Griffith LE, Walter SD. The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials. J Clin Epidemiol. 1997;50(6):683\u201391.","journal-title":"J Clin Epidemiol."},{"key":"417_CR6","unstructured":"NICE. Agomelatine for the treatment of major depressive episodes (terminated appraisal). 2011. Available at: https:\/\/www.nice.org.uk\/guidance\/ta231 . Accessed 2 June 2016."},{"issue":"2","key":"417_CR7","doi-asserted-by":"crossref","first-page":"109","DOI":"10.4088\/JCP.09m05347blu","volume":"71","author":"S Kasper","year":"2010","unstructured":"Kasper S, Hajak G, Wulff K, Hoogendijk WJG, Montejo AL, Smeraldi E, et al. Efficacy of the novel antidepressant agomelatine on the circadian rest-activity cycle and depressive and anxiety symptoms in patients with major depressive disorder: a randomized, double-blind comparison with sertraline. J Clin Psychiatry. 2010;71(2):109\u201320.","journal-title":"J Clin Psychiatry."},{"issue":"3","key":"417_CR8","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1503\/jpn.140120","volume":"40","author":"C-U Pae","year":"2015","unstructured":"Pae C-U, Wang S-M, Han C, Lee SJ, Patkar AA, Masand PS, et al. Vortioxetine: a meta-analysis of 12 short-term, randomized, placebo-controlled clinical trials for the treatment of major depressive disorder. J Psychiatry Neurosci. 2015;40(3):174\u201386.","journal-title":"J Psychiatry Neurosci."},{"issue":"12","key":"417_CR9","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.1185\/03007995.2014.969566","volume":"30","author":"P-M Llorca","year":"2014","unstructured":"Llorca P-M, Lan\u00e7on C, Brignone M, Rive B, Salah S, Ereshefsky L, et al. Relative efficacy and tolerability of vortioxetine versus selected antidepressants by indirect comparisons of similar clinical studies. Curr Med Res Opin. 2014;30(12):2589\u2013606.","journal-title":"Curr Med Res Opin."},{"issue":"2","key":"417_CR10","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1177\/070674370404900207","volume":"49","author":"F Limosin","year":"2004","unstructured":"Limosin F, Loze J-Y, Zylberman-Bouhassira M, Schmidt ME, Perrin E, Rouillon F. The course of depressive illness in general practice. Can J Psychiatry. 2004;49(2):119\u201323.","journal-title":"Can J Psychiatry."},{"issue":"11","key":"417_CR11","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1176\/ajp.2006.163.11.1905","volume":"163","author":"AJ Rush","year":"2006","unstructured":"Rush AJ, Trivedi MH, Wisniewski SR, Nierenberg AA, Stewart JW, Warden D, et al. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report\u201d. Am J Psychiatry. 2006;163(11):1905\u201317.","journal-title":"Am J Psychiatry."},{"issue":"2","key":"417_CR12","doi-asserted-by":"crossref","first-page":"157","DOI":"10.2165\/11537360-000000000-00000","volume":"29","author":"S Byford","year":"2011","unstructured":"Byford S, Barrett B, Despi\u00e9gel N, Wade A. Impact of treatment success on health service use and cost in depression: longitudinal database analysis. Pharmacoeconomics. 2011;29(2):157\u201370.","journal-title":"Pharmacoeconomics."},{"key":"417_CR13","unstructured":"Curtis L. Unit costs of health and social care 2013. Personal Social Services Research Unit; 2013. Available at: http:\/\/www.pssru.ac.uk\/project-pages\/unit-costs\/2013\/ .Accessed 2 June 2016."},{"key":"417_CR14","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1477-7525-2-20","volume":"2","author":"C Sapin","year":"2004","unstructured":"Sapin C, Fantino B, Nowicki M-L, Kind P. Usefulness of EQ-5D in assessing health status in primary care patients with major depressive disorder. Health Qual Life Outcomes. 2004;2:20.","journal-title":"Health Qual Life Outcomes."},{"issue":"13","key":"417_CR15","doi-asserted-by":"crossref","first-page":"911","DOI":"10.2165\/00023210-200418130-00006","volume":"18","author":"PW Sullivan","year":"2004","unstructured":"Sullivan PW, Valuck R, Saseen J, MacFall HM. A comparison of the direct costs and cost effectiveness of serotonin reuptake inhibitors and associated adverse drug reactions. CNS Drugs. 2004;18(13):911\u201332.","journal-title":"CNS Drugs."}],"container-title":["PharmacoEconomics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40273-016-0417-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40273-016-0417-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40273-016-0417-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T12:11:29Z","timestamp":1498306289000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40273-016-0417-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,11]]},"references-count":15,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["417"],"URL":"https:\/\/doi.org\/10.1007\/s40273-016-0417-9","relation":{},"ISSN":["1170-7690","1179-2027"],"issn-type":[{"type":"print","value":"1170-7690"},{"type":"electronic","value":"1179-2027"}],"subject":[],"published":{"date-parts":[[2016,6,11]]}}}